Watch our October 2020 briefing, Counterfeit Medicine: Crime and Policy 2020, a summary of the major cases we've seen this year, the trends that worry us, and current drug supply chain policy issues, followed by a ten minute Q&A session with PSM Executive Director Shabbir Imber Safdar.
A summary briefing of 2020’s major cases, worrying trends and a deep dive into drug supply chain policy issues.
In PSM’s round-up this week: new reports about counterfeit medicine, drug supply chain regulation and phishing scams; FDA warnings about dangerous supplements; a life sentence for fake pill kingpin Aaron Shamo; and more.
In this analysis, which was published in Lexology on October 13, 2020, three global regulatory experts examine barriers to drug importation.
In PSM’s round-up this week: Policy truths about drug importation, prosecutions for fake COVID-19 treatments and financial fraud, and another week in counterfeit pills.
In the first seven months of 2020, the Arizona Department of Health Services reported over 2,700 newly suspected opioid overdose deaths in Arizona. What makes this figure more startling is that there were just over 3,800 suspected opioid deaths in the preceding 30 months. The problem is escalating, and rapidly.